Wu SL, Wei TY, Lin SW, Su KY, Kuo CH
Lilly's press release notes that this is the first investigational drug to reduce body weight by more than 20% on average in a Phase 3 clinical trial
Effectiveness: What to Expect Patient-reported outcomes with ipamorelin nasal spray are typically characterized by: Improved sleep quality, often within the first 14 weeks Gradual changes in recovery and body composition over months Less intense subjective GH feel than high-dose injection protocols Generally good tolerability with occasional mild nasal irritation Comparative effectiveness against injection: at matched peptide exposure, the two routes produce similar pharmacodynamic effects
Not for human, animal, diagnostic, or household use
The peptide enters the bloodstream directly regardless of digestive state
Because of its positively charged structure, chitosan can interact with negatively charged compounds and may help bind certain toxins, including some mycotoxins, in experimental models